FX Week is proud to present the 10th annual FX Invest Europe conference, bringing together leading buy-side practitioners in the fast developing foreign exchange and currency markets. It is a must-attend event for those who want to better understand the implications of recent market developments

Risk.net's award-winning OpRisk North America is back for its 19th year! This industry must-attend conference gathers 550+ senior operational risk directors from leading tier 1 banks, buy-side firms and regulators from across the globe.

Structured Products runs three global awards programmes - for the Americas, Asia, and Europe - to celebrate excellence across the structured products markets. The Structured Products awards are the industry's most prestigious honour, designed to recognise the top buyside and sellside firms.

The OpRisk Awards recognise the outstanding achievers across the operational risk markets, including banks, insurers, regulators, consultants and vendors. We celebrate the industry's hard work in style and the awards ceremony is a great opportunity to network and find out about companies performance

This white paper discusses how effective financial crime prevention can not only mitigate the risk of threats to an organization and to its customers, but how it can also provide additional benefits such as operational efficiency and improved customer experience.

Now in its 10th year, the RiskTech100 is globally acknowledged as the most comprehensive study of the world's most significant risk and compliance technology companies. This report covers the key market trends and ranks the top 100 technology vendors in this sector.

£90K- £120K + Bens & Bonus :
Compliance Recruitment Solutions:
Our client, a global fund management firm, is seeking to recruit for a newly created role. Frequently liaising at senior level within the business ...
West End

Independent third-party to take over Trac-x imminently

Navroz Patel

17 October 2003

Tweet

Facebook

LinkedIn

Google plus

Save this article

Send to

Members of both firms’ credit derivatives teams have admitted that these problems accelerated the execution of a long-held plan to transfer Trac-x to an independent third-party. RiskNews spoke with a source familiar with the negotiations, who named New York-based index provider Dow Jones as being the most likely candidate to take over Trac-x. JP Morgan and Morgan Stanley declined to name the third party. However, the financial information specialist exclusively told RiskNews that its Dow Jones Indexes division is “having conversations” with JP Morgan and Morgan Stanley about the Trac-x product. “We expect to announce more details about this in the next couple of days,” a spokeswoman added.

Two US-based Trac-x end-users, who spoke on condition of anonymity, told RiskNews that some firms were unhappy with the way JP Morgan and Morgan Stanley handled the Trac-x index’s reconstitution earlier this month. “There appeared to be a definite lack of communication for such a significant change in the underlying reference credits,” said one loan book manager at a North American bank. “We are not saying the process couldn’t have been handled better, but there was nothing malicious about it and we gained no competitive advantage,” JP Morgan’s Palmer claimed.

According to some traders, several firms have bristled at the level of disclosure required by the licensing agreements penned by Morgan Stanley and JP Morgan for Trac-x. Lisa Watkinson, Morgan Stanley’s global product manager for flow credit default swaps and credit indexation, said a few firms were “upset” by the way intellectual property rights were handled in licensing agreements. “We accepted their arguments, and dropped those elements from agreements back in September,” she added. Previously, licensees were required to obtain permission to structure non-standard derivatives based on Trac-x. RiskNews understands that Merrill Lynch, Goldman Sachs and Deutsche Bank were the most vocal in their dissent.

When the reconstitution of the index prior to its roll-out became a new flashpoint, Morgan Stanley appears to have been equally accommodating; it offered to make the reconstitution process more open and democratic, Watkinson told RiskNews.

However, by this time plans were already afoot among other dealers to create a rival product to Trac-x in the US. On October 16, a consortium of 11 credit derivatives dealers announced the launch of a 125-name tradable credit default swap index, dubbed ‘iBoxx CDX.NA.IG’.

The iBoxx product – jointly launched by ABN Amro, Barclays Capital, Bear Stearns, Citigroup, Credit Suisse First Boston, Deutsche Bank, Goldman Sachs, HSBC, Lehman Brothers, Merrill Lynch and UBS – will begin trading next Monday, according to the consortium’s official statement. The 125 names in iBoxx CDX.NA.IG are equally weighted, and were determined using transparent rules designed to select a representative group of diversified US investment-grade borrowers, the consortium said. “We expect the combination of dealer support and investor acceptance will rapidly make iBoxx CDX.NA.IG the new standard for US investment-grade CDS index trading.”

Watkinson is baffled by the decision to create a rival product. "If the Trac-x product was lacking in some way and we were adverse to changing it, then maybe a new product would make sense," Watkinson said. "But unless you’re really adding value, launching a competing product just harms liquidity," she added. Meanwhile, JP Morgan’s Palmer told RiskNews he was “pleasantly surprised” that the new [iBoxx] product looked so similar to Trac-x, and that it would also be a surprise if it were to usurp Trac-x.

Some firms are hedging their bets though. The day after the official announcement of the new iBoxx product, three of the iBoxx consortium – Bear Stearns, Lehman Brothers and HSBC – signed licensing agreements to make markets in Trac-x.